Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.
Wheater
Matthew J
MJ
Department of Medical Oncology, Southampton General Hospital, Southampton, United Kingdom.
Mead
Graham M
GM
Bhandari
Sandeep
S
Fennell
Jonathan
J
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D014408:Biomarkers, Tumor / Q000097:blood; D001932:Brain Neoplasms / Q000556:secondary; D031954:Choriocarcinoma, Non-gestational / Q000188:drug therapy / Q000556:secondary*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D015942:Factor VIIa / Q000627:therapeutic use*; D006469:Hemoptysis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use; D012186:Retroperitoneal Neoplasms / Q000473:pathology*; D014057:Tomography, X-Ray Computed
D014408:Biomarkers, Tumor; D018997:Chorionic Gonadotropin, beta Subunit, Human; D011994:Recombinant Proteins; D015942:Factor VIIa